D. Hanson

发表

A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users

Steffanie A Strathdee, Holly Hagan, R. Garfein, 2007, AIDS.

Detailed Transmission Network Analysis of a Large Opiate-Driven Outbreak of HIV Infection in the United States

Debra Hanson, Michael W. Spiller, Philip J Peters, 2017, The Journal of infectious diseases.

Correction of Bias in Imputing Missing Values of Categorical Variables

Ruiguang Song, H. I. Hall, D. Hanson, 2009 .

Short communication: Viremic control is independent of repeated low-dose SHIVSF162p3 exposures.

J. Mcnicholl, D. Hanson, Charles Dobard, 2014, AIDS research and human retroviruses.

Susceptibility to repeated, low-dose, rectal SHIVSF162P3 challenge is independent of TRIM5 genotype in rhesus macaques.

W. Heneine, J. Mcnicholl, D. Hanson, 2013, AIDS research and human retroviruses.

Protection Against Rectal Chimeric Simian/Human Immunodeficiency Virus Transmission in Macaques by Rectal-Specific Gel Formulations of Maraviroc and Tenofovir.

W. Heneine, I. McGowan, Lin Wang, 2015, The Journal of infectious diseases.

Time Until Emergence of HIV Test Reactivity Following Infection With HIV-1: Implications for Interpreting Test Results and Retesting After Exposure

Kevin P Delaney, S. Owen, D. Hanson, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Pregnancy rates among women infected with human immunodeficiency virus

S. Chu, D. Hanson, Jefferey Jones, 1996, Obstetrics and gynecology.

Protection from Mycobacterium avium complex disease in human immunodeficiency virus-infected persons with a history of tuberculosis.

C. Horsburgh, S. Thompson, D. Hanson, 1996, The Journal of infectious diseases.

Incidence and Trends in Kaposi’s Sarcoma in the Era of Effective Antiretroviral Therapy

H. Jaffe, Jeffrey L. Jones, D. Hanson, 2000, Journal of acquired immune deficiency syndromes.

Discontinuation of primary prophylaxis against Mycobacterium avium complex infection in HIV-infected persons receiving antiretroviral therapy: observations from a large national cohort in the United States, 1992-2002.

D. Swerdlow, J. Brooks, M. Wolfe, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Viral load as an independent risk factor for opportunistic infections in HIV-infected adults and adolescents

Jeffrey L. Jones, J. Kaplan, D. Hanson, 2001, AIDS.

Distribution of CD4+ T lymphocytes at diagnosis of acquired immunodeficiency syndrome-defining and other human immunodeficiency virus-related illnesses. The Adult and Adolescent Spectrum of HIV Disease Project Group.

J. Ward, S. Chu, D. Hanson, 1995, Archives of internal medicine.

USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: Disease-specific recommendations

Mary E. Wilson, J. Hughes, J. Phair, 1995 .

Trends in Pregnancy Rates Among Women With Human Immunodeficiency Virus

Jeffrey L. Jones, D. Hanson, M. Dworkin, 2004, Obstetrics and gynecology.

Delayed Maturation of Antibody Avidity but Not Seroconversion in Rhesus Macaques Infected With Simian HIV During Oral Pre-Exposure Prophylaxis

W. Heneine, S. Owen, K. Curtis, 2011, Journal of acquired immune deficiency syndromes.

Brief Report: HIV-1 Evolution in Breakthrough Infections in a Human Trial of Oral Pre-exposure Prophylaxis With Emtricitabine and Tenofovir Disoproxil Fumarate

W. Heneine, Allan W. Taylor, J. Brooks, 2016, Journal of acquired immune deficiency syndromes.

Surveillance for AIDS-defining opportunistic illnesses, 1992-1997.

J. Ward, Jeffrey L. Jones, D. Alderton, 1999, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

Effect of antiretroviral therapy on recent trends in selected cancers among HIV-infected persons. Adult/Adolescent Spectrum of HIV Disease Project Group.

J. Ward, H. Jaffe, D. Hanson, 1998, Journal of acquired immune deficiency syndromes.

Survival of patients with AIDS, after diagnosis of Pneumocystis carinii pneumonia, in the United States.

T. Navin, D. Hanson, M. Dworkin, 2001, The Journal of infectious diseases.

Entamoeba histolytica/Entamoeba dispar infections in human immunodeficiency virus-infected patients in the United States.

S. Lowther, D. Hanson, M. Dworkin, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Projections of the number of persons diagnosed with AIDS and the number of immunosuppressed HIV-infected persons--United States, 1992-1994.

R. Brookmeyer, P. Rosenberg, M. Gail, 1992, MMWR. Morbidity and mortality weekly report.

HIV-associated tuberculosis in the era of highly active antiretroviral therapy. The Adult/Adolescent Spectrum of HIV Disease Group.

Jeffrey L. Jones, K. Decock, D. Hanson, 2000, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

The reporting of HIV/AIDS deaths in women.

S. Chu, J. Buehler, D. Hanson, 1992, American journal of public health.

Epidemiology of anemia in human immunodeficiency virus (HIV)-infected persons: results from the multistate adult and adolescent spectrum of HIV disease surveillance project.

P. Sullivan, J. Ward, S. Chu, 1998, Blood.

Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT).

R. Garfein, P. Kerndt, H. Hagan, 2007, Drug and alcohol dependence.

Surveillance of AIDS‐defining conditions in the United States

J. Ward, S. Chu, Jeffrey L. Jones, 1994, AIDS.

Trends in perimortal conditions and mortality rates among HIV-infected patients

S. Buskin, A. McNaghten, R. Selik, 2007, AIDS.

Opportunistic Infections (OIs) as Emerging Infectious Diseases: Challenges Posed by OIs in the 1990s and Beyond

C. Beard, Jeffrey L. Jones, J. Kaplan, 1998 .

HIV type 1 drug resistance in adults receiving highly active antiretroviral therapy in Abidjan, Côte d'Ivoire.

S. Eholie, J. Nkengasong, T. Chorba, 2009, AIDS research and human retroviruses.

Surveillance for thrombocytopenia in persons infected with HIV: results from the multistate Adult and Adolescent Spectrum of Disease Project.

P. Sullivan, S. Chu, C. Ciesielski, 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Increased susceptibility to vaginal simian/human immunodeficiency virus transmission in pig-tailed macaques coinfected with Chlamydia trachomatis and Trichomonas vaginalis.

J. Papp, H. Caldwell, J. Mcnicholl, 2014, The Journal of infectious diseases.

Postexposure Protection of Macaques from Vaginal SHIV Infection by Topical Integrase Inhibitors

W. Heneine, D. Hazuda, U. Parikh, 2014, Science Translational Medicine.

Integrase Inhibitors Postexposure Protection of Macaques from Vaginal SHIV Infection by

W. Heneine, D. Hazuda, U. Parikh, 2014 .

Projections of the number of persons diagnosed with AIDS and the number of immunosuppressed HIV-infected persons--United States, 1992-1994.

R. Brookmeyer, P. Rosenberg, M. Gail, 1992, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy.

M. Lindegren, S. Holmberg, Jeffrey L. Jones, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Natural Substrate Concentrations Can Modulate the Prophylactic Efficacy of Nucleotide HIV Reverse Transcriptase Inhibitors

William A. Lee, W. Heneine, J. Rooney, 2011, Journal of Virology.

Combination Emtricitabine and Tenofovir Disoproxil Fumarate Prevents Vaginal Simian/Human Immunodeficiency Virus Infection in Macaques Harboring Chlamydia trachomatis and Trichomonas vaginalis.

W. Heneine, J. Papp, J. Mcnicholl, 2016, The Journal of infectious diseases.

Combination emtricitabine and tenofovir disoproxil fumarate prevents vaginal SHIV infection in macaques harboring C . trachomatis and T . vaginalis

W. Heneine, J. Papp, J. Mcnicholl, 2016 .

Resistance to Simian HIV Infection Is Associated With High Plasma Interleukin-8, RANTES and Eotaxin in a Macaque Model of Repeated Virus Challenges

P. Guenthner, S. Butera, D. Hanson, 2010, Journal of acquired immune deficiency syndromes.

Effect of influenza vaccination on disease progression among HIV-infected persons

P. Sullivan, J. Ward, Jeffrey L. Jones, 2000, AIDS.

Distribution of CD4+ T lymphocytes at diagnosis of acquired immunodeficiency syndrome-defining and other human immunodeficiency virus-related illnesses

J. Ward, S. Chu, D. Hanson, 1995 .

USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: introduction. USPHS/IDSA Prevention of Opportunistic Infections Working Group.

K. Holmes, H. Masur, L. Schonberger, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Current Epidemiology of Pneumocystis Pneumonia

C. Beard, H. Masur, J. Lundgren, 2004, Emerging infectious diseases.

Aspergillosis among people infected with human immunodeficiency virus: incidence and survival. Adult and Adolescent Spectrum of HIV Disease Project.

P. Sullivan, D. Hanson, J. Jones, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Trends in AIDS-related opportunistic infections among men who have sex with men and among injecting drug users, 1991-1996.

J. Ward, J. Kaplan, D. Hanson, 1998, The Journal of infectious diseases.

Impact on Hemoglobin of Starting Combination Antiretroviral Therapy With or Without Zidovudine in Anemic HIV-Infected Patients

P. Sullivan, J. Brooks, D. Hanson, 2008, Journal of acquired immune deficiency syndromes.

Epidemiology of Anemia in Human Immunodeficiency Virus (HIV)-Infected Persons: Results From the Multistate Adult and Adolescent Spectrum of HIV Disease Surveillance Project

P. Sullivan, J. Ward, S. Chu, 1998 .

Standardization and Monitoring of Laboratory Performance and Quality Assurance by Use of the Less-Sensitive HIV Incidence Assay: Seven Years of Results

B. Branson, Laurie Linley, D. Hanson, 2011, Journal of acquired immune deficiency syndromes.

Risk factors for primary Pneumocystis carinii pneumonia in human immunodeficiency virus-infected adolescents and adults in the United States: reassessment of indications for chemoprophylaxis.

T. Navin, Jeffrey L. Jones, J. Kaplan, 1998, The Journal of infectious diseases.

Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003.

P. Sullivan, A. Moorman, S. Holmberg, 2008, Annals of internal medicine.

Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus-infected subjects.

A. McNaghten, P. Fleming, S. Kellerman, 2003, The Journal of infectious diseases.

Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy

P. Sullivan, J. Brooks, E. Teshale, 2006, AIDS.

Physiologic doses of depot-medroxyprogesterone acetate do not increase acute plasma simian HIV viremia or mucosal virus shedding in pigtail macaques

W. Heneine, D. Hanson, K. Hanley, 2014, AIDS.

Virologic and immunologic response to antiretroviral therapy and predictors of HIV type 1 drug resistance in children receiving treatment in Abidjan, Côte d'Ivoire.

M. Nolan, E. Bissagnéné, J. Nkengasong, 2008, AIDS research and human retroviruses.

Durable Protection from Vaginal Simian-Human Immunodeficiency Virus Infection in Macaques by Tenofovir Gel and Its Relationship to Drug Levels in Tissue

W. Heneine, Z. Kuklenyik, Sunita Sharma, 2011, Journal of Virology.

When to begin highly active antiretroviral therapy? Evidence supporting initiation of therapy at CD4+ lymphocyte counts <350 cells/microL.

S. Buskin, J. Karon, D. Cohn, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A Depot Medroxyprogesterone Acetate Dose That Models Human Use and Its Effect on Vaginal SHIV Acquisition Risk

J. Mcnicholl, D. Hanson, Shanon Ellis, 2016, Journal of acquired immune deficiency syndromes.

Quantification of HIV-1 p24 by a highly improved ELISA: an alternative to HIV-1 RNA based treatment monitoring in patients from Abidjan, Côte d'Ivoire.

J. Böni, J. Nkengasong, D. Yavo, 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Novel simian foamy virus infections from multiple monkey species in women from the Democratic Republic of Congo

W. Heneine, M. Lebreton, U. Tamoufé, 2011, Retrovirology.

Estimation of the temporal probability of human immunodeficiency virus (HIV) dementia after risk stratification for HIV‐infected persons

R. Janssen, A. Qureshi, Jeffrey L. Jones, 1998, Neurology.

Cross-Sectional HIV Incidence Surveillance: A Benchmarking of Approaches for Estimating the ‘Mean Duration of Recent Infection’

Reshma Kassanjee, Daniela De Angelis, Marian Farah, 2017, Statistical communications in infectious diseases.

Performance of the Aptima HIV-1 RNA Qualitative Assay with 16- and 32-Member Specimen Pools

M. Parker, P. Patel, C. Hart, 2010, Journal of Clinical Microbiology.

Declines in AIDS incidence and deaths in the USA: a signal change in the epidemic.

J. Ward, J. Karon, K. D. de Cock, 1998, AIDS.

Differences in HIV-2 plasma viral load and immune activation in HIV-1 and HIV-2 dually infected persons and those infected with HIV-2 only in Abidjan, Côte D'Ivoire

J. Nkengasong, T. Chorba, S. Wiktor, 2004, AIDS.

Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance

P. Weidle, P. Mugyenyi, J. Mermin, 2002, The Lancet.

Trends in the Treatment of Anemia Using Recombinant Human Erythropoietin in Patients with HIV Infection

P. Sullivan, J. Brooks, D. Hanson, 2011, The open AIDS journal.

Virologic and immunologic outcomes and programmatic challenges of an antiretroviral treatment pilot project in Abidjan, Côte d'Ivoire

J. Saba, J. Nkengasong, T. Chorba, 2003, AIDS.

Risk factors for and trends in gonorrhea incidence among persons infected with HIV in the United States

Jeffrey L. Jones, A. Do, D. Hanson, 2001, AIDS.

AIDS-associated Kaposi's sarcoma

J. Ward, S. Chu, H. Jaffe, 1995, Science.

Reduced inflammation and CD4 loss in acute SHIV infection during oral pre-exposure prophylaxis.

W. Heneine, J. Mcnicholl, D. Hanson, 2012, The Journal of infectious diseases.

Reduced In fl ammation and CD 4 Loss in Acute SHIV Infection During Oral Pre-Exposure Prophylaxis

W. Heneine, J. Mcnicholl, D. Hanson, 2012 .

Prophylaxis against Pneumocystis carinii pneumonia among children with perinatally acquired human immunodeficiency virus infection in the United States

M. Lindegren, B. Caldwell, P. Thomas, 1995, The New England journal of medicine.

HIV testing factors associated with delayed entry into HIV medical care among HIV-infected persons from eighteen states, United States, 2000-2004.

P. Sullivan, A. McNaghten, L. Gardner, 2009, AIDS patient care and STDs.

Cataloguing of Potential HIV Susceptibility Factors during the Menstrual Cycle of Pig-Tailed Macaques by Using a Systems Biology Approach

T. Ball, P. Guenthner, A. Burgener, 2015, Journal of Virology.

Topical tenofovir protects against vaginal simian HIV infection in macaques coinfected with Chlamydia trachomatis and Trichomonas vaginalis

W. Heneine, J. Papp, J. Mcnicholl, 2017, AIDS.

Progressive multifocal leukoencephalopathy: improved survival of human immunodeficiency virus-infected patients in the protease inhibitor era.

Jeffrey L. Jones, D. Hanson, J. Jones, 1999, The Journal of infectious diseases.

HIV Infection among Patients in U.S. Acute Care Hospitals

Glen A. Satten, John W. Ward, G. Satten, 1992 .

Intermittent Prophylaxis with Oral Truvada Protects Macaques from Rectal SHIV Infection

W. Heneine, Z. Kuklenyik, J. Barr, 2010, Science Translational Medicine.

Complete Protection from Repeated Vaginal Simian-Human Immunodeficiency Virus Exposures in Macaques by a Topical Gel Containing Tenofovir Alone or with Emtricitabine

W. Heneine, P. Guenthner, U. Parikh, 2009, Journal of Virology.

HIV-1 RNA rectal shedding is reduced in men with low plasma HIV-1 RNA viral loads and is not enhanced by sexually transmitted bacterial infections of the rectum.

J. Brooks, K. Mayer, J. Lennox, 2011, The Journal of infectious diseases.

Protection against Rectal Transmission of an Emtricitabine-Resistant Simian/Human Immunodeficiency Virus SHIV162p3M184V Mutant by Intermittent Prophylaxis with Truvada

W. Heneine, D. Hanson, Ae S. Youngpairoj, 2011, Journal of Virology.

Repeated Vaginal SHIV Challenges in Macaques Receiving Oral or Topical Preexposure Prophylaxis Induce Virus-Specific T-Cell Responses

W. Heneine, T. Tsegaye, J. Mcnicholl, 2015, Journal of acquired immune deficiency syndromes.

Targeting α4β7 integrin reduces mucosal transmission of SIV and protects GALT from infection

M. Brameier, A. Fauci, K. Reimann, 2014, Nature Medicine.

Targeting α4β7 integrin reduces mucosal transmission of SIV and protects GALT from infection

M. Brameier, A. Fauci, K. Reimann, 2014, Nature medicine.

Targeting alpha(4)beta(7) integrin reduces mucosal transmission of simian immunodeficiency virus and protects gut-associated lymphoid tissue from infection

Paul, M. Brameier, A. Fauci, 2022 .

Prophylactic efficacy of oral emtricitabine and tenofovir disoproxil fumarate combination therapy against a tenofovir-resistant simian/human immunodeficiency virus containing the K65R mutation in macaques.

W. Heneine, D. Hanson, J. García-Lerma, 2013, The Journal of infectious diseases.

Prophylactic Ef fi cacy of Oral Emtricitabine and Tenofovir Disoproxil Fumarate Combination Therapy Against a Tenofovir-Resistant Simian / Human Immunode fi ciency Virus Containing the K 65 R Mutation in Macaques

W. Heneine, D. Hanson, S. Bachman, 2013 .

Efficacy of topical tenofovir against transmission of a tenofovir-resistant SHIV in macaques

W. Heneine, Sunita Sharma, C. Pau, 2015, Retrovirology.

Incidence and trends in Kaposi's sarcoma in the era of effective antiretroviral therapy.

H. Jaffe, Jeffrey L. Jones, D. Hanson, 2000 .

Effects of antiretroviral therapy and opportunistic illness primary chemoprophylaxis on survival after AIDS diagnosis. Adult/Adolescent Spectrum of Disease Group.

J. Ward, A. McNaghten, Jeffery L. Jones, 1999, AIDS.

Effectiveness of 23-valent polysaccharide pneumococcal vaccine on pneumonia in HIV-infected adults in the United States, 1998--2003.

P. Sullivan, A. Schuchat, B. Flannery, 2008, Vaccine.

Pneumococcal disease among human immunodeficiency virus-infected persons: incidence, risk factors, and impact of vaccination.

J. Ward, Jeffrey L. Jones, J. Kaplan, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Relationship of Estimated SHIV Acquisition Time Points During the Menstrual Cycle and Thinning of Vaginal Epithelial Layers in Pigtail Macaques

S. Zaki, J. Mcnicholl, D. Hanson, 2015, Sexually transmitted diseases.

Self-collected genital swabs compared with cervicovaginal lavage for measuring HIV-1 and HSV-2 and the effect of acyclovir on viral shedding

S. Whitehead, J. Mcnicholl, L. Markowitz, 2016, International journal of STD & AIDS.

Estimating the number of AIDS-defining opportunistic illness diagnoses from data collected under the 1993 AIDS surveillance definition.

J. Ward, J. Karon, D. Hanson, 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Risk for Preventable Opportunistic Infections in Persons with Aids after Antiretroviral Therapy Increases Cd4 + T Lymphocyte Counts above Prophylaxis Thresholds and the Adult/adolescent Spectrum of Hiv Disease Project A

J. Ward, Jeffrey L. Jones, J. Kaplan, 2022 .

Differences in Prescription of Antiretroviral Therapy in a Large Cohort of HIV-Infected Patients

A. Davidson, E. Mokotoff, S. Buskin, 2003, Journal of acquired immune deficiency syndromes.

Toxoplasmic encephalitis in HIV-infected persons: risk factors and trends

J. Ward, S. Chu, T. Navin, 1996, AIDS.

Survival prognosis of HIV-infected patients.

C. Horsburgh, C R Horsburgh, S. Thompson, 1993, Journal of acquired immune deficiency syndromes.

Reasons for lack of appropriate receipt of primary Pneumocystis jiroveci pneumonia prophylaxis among HIV-infected persons receiving treatment in the United States: 1994-2003.

P. Sullivan, J. Brooks, E. Teshale, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Lower-Sensitivity and Avidity Modifications of the Vitros Anti-HIV 1+2 Assay for Detection of Recent HIV Infections and Incidence Estimation

Debra Hanson, Oliver Laeyendecker, Michael P. Busch, 2012, Journal of Clinical Microbiology.

Evaluation of a Multiplex Assay for Estimation of HIV-1 Incidence

S. Owen, S. Michele Owen, K. Curtis, 2013, PloS one.

Mean Recency Period for Estimation of HIV-1 Incidence with the BED-Capture EIA and Bio-Rad Avidity in Persons Diagnosed in the United States with Subtype B

Angela L Hernandez, S. Owen, D. Hanson, 2016, PloS one.

Performance characteristics of an antibody-based multiplex kit for determining recent HIV-1 infection

S. Owen, K. Curtis, D. Hanson, 2017, PloS one.

A Multiplex HIV Incidence Assay for Inferring Recent HIV-1 Transmission and Time of Infection

Ellsworth M. Campbell, P. Peters, J. Lovchik, 2019, Journal of acquired immune deficiency syndromes.

Determination of mean recency period for estimation of HIV type 1 Incidence with the BED-capture EIA in persons infected with diverse subtypes.

Bernard Branson, John Hargrove, B. Branson, 2011, AIDS research and human retroviruses.

HIV-infected Injection Drug Users: Health Care Utilization and Morbidity

S. Buskin, E. Teshale, D. Hanson, 2007, Journal of health care for the poor and underserved.

How important is race/ethnicity as an indicator of risk for specific AIDS-defining conditions?

J. Ward, S. Chu, K. Castro, 1995, Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology.

Prophylaxis against Pneumocystis carinii pneumonia at higher CD4+ T-cell counts.

J. Ward, S. Chu, C. Ciesielski, 1995, JAMA.

Detailed Molecular Epidemiologic Characterization of HIV-1 Infection in Bulgaria Reveals Broad Diversity and Evolving Phylodynamics

W. Switzer, D. Paraskevis, A. Shankar, 2013, PloS one.

Prevalence of genotypic and phenotypic HIV‐1 drug‐resistant strains among patients who have rebound in viral load while receiving antiretroviral therapy in the UNAIDS–Drug Access Initiative in Abidjan, Côte d'Ivoire

K. Hertogs, B. Larder, M. Peeters, 2003, AIDS.